Glioblastoma multiforme

Advances in postsurgical management

Geetika Klevos, Stefan Madajewicz, James Manzione, Dinko Franceschi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor in adults, striking 8,000 to 10,000 people per year in North America alone. Even under the most favorable circumstances, patients die within the first 2 years of diagnosis. Recent advances in diagnostic imaging, microsurgical techniques, and medical management of this rare malignancy have led to more accurate diagnoses, staging, improvement in quality of life, and overall survival. In this review, the authors briefly summarize the pathogenesis and clinical presentation of GBM and then describe their experience in treating this disease after surgery using intraarterial chemotherapy-itself an unusual and still investigational approach-followed by concomitant radiotherapy and oral temozolomide therapy and then adjuvant maintenance therapy with temozolomide alone.

Original languageEnglish (US)
Pages (from-to)678-683
Number of pages6
JournalCommunity Oncology
Volume3
Issue number10
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

temozolomide
Glioblastoma
Diagnostic Imaging
North America
Brain Neoplasms
Radiotherapy
Quality of Life
Drug Therapy
Survival
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Klevos, G., Madajewicz, S., Manzione, J., & Franceschi, D. (2006). Glioblastoma multiforme: Advances in postsurgical management. Community Oncology, 3(10), 678-683.

Glioblastoma multiforme : Advances in postsurgical management. / Klevos, Geetika; Madajewicz, Stefan; Manzione, James; Franceschi, Dinko.

In: Community Oncology, Vol. 3, No. 10, 10.2006, p. 678-683.

Research output: Contribution to journalArticle

Klevos, G, Madajewicz, S, Manzione, J & Franceschi, D 2006, 'Glioblastoma multiforme: Advances in postsurgical management', Community Oncology, vol. 3, no. 10, pp. 678-683.
Klevos G, Madajewicz S, Manzione J, Franceschi D. Glioblastoma multiforme: Advances in postsurgical management. Community Oncology. 2006 Oct;3(10):678-683.
Klevos, Geetika ; Madajewicz, Stefan ; Manzione, James ; Franceschi, Dinko. / Glioblastoma multiforme : Advances in postsurgical management. In: Community Oncology. 2006 ; Vol. 3, No. 10. pp. 678-683.
@article{dbf6e5881a9b46e193971c4c76390bc2,
title = "Glioblastoma multiforme: Advances in postsurgical management",
abstract = "Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor in adults, striking 8,000 to 10,000 people per year in North America alone. Even under the most favorable circumstances, patients die within the first 2 years of diagnosis. Recent advances in diagnostic imaging, microsurgical techniques, and medical management of this rare malignancy have led to more accurate diagnoses, staging, improvement in quality of life, and overall survival. In this review, the authors briefly summarize the pathogenesis and clinical presentation of GBM and then describe their experience in treating this disease after surgery using intraarterial chemotherapy-itself an unusual and still investigational approach-followed by concomitant radiotherapy and oral temozolomide therapy and then adjuvant maintenance therapy with temozolomide alone.",
author = "Geetika Klevos and Stefan Madajewicz and James Manzione and Dinko Franceschi",
year = "2006",
month = "10",
language = "English (US)",
volume = "3",
pages = "678--683",
journal = "Community Oncology",
issn = "1548-5315",
publisher = "BioLink Communications",
number = "10",

}

TY - JOUR

T1 - Glioblastoma multiforme

T2 - Advances in postsurgical management

AU - Klevos, Geetika

AU - Madajewicz, Stefan

AU - Manzione, James

AU - Franceschi, Dinko

PY - 2006/10

Y1 - 2006/10

N2 - Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor in adults, striking 8,000 to 10,000 people per year in North America alone. Even under the most favorable circumstances, patients die within the first 2 years of diagnosis. Recent advances in diagnostic imaging, microsurgical techniques, and medical management of this rare malignancy have led to more accurate diagnoses, staging, improvement in quality of life, and overall survival. In this review, the authors briefly summarize the pathogenesis and clinical presentation of GBM and then describe their experience in treating this disease after surgery using intraarterial chemotherapy-itself an unusual and still investigational approach-followed by concomitant radiotherapy and oral temozolomide therapy and then adjuvant maintenance therapy with temozolomide alone.

AB - Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor in adults, striking 8,000 to 10,000 people per year in North America alone. Even under the most favorable circumstances, patients die within the first 2 years of diagnosis. Recent advances in diagnostic imaging, microsurgical techniques, and medical management of this rare malignancy have led to more accurate diagnoses, staging, improvement in quality of life, and overall survival. In this review, the authors briefly summarize the pathogenesis and clinical presentation of GBM and then describe their experience in treating this disease after surgery using intraarterial chemotherapy-itself an unusual and still investigational approach-followed by concomitant radiotherapy and oral temozolomide therapy and then adjuvant maintenance therapy with temozolomide alone.

UR - http://www.scopus.com/inward/record.url?scp=33845611541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845611541&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 678

EP - 683

JO - Community Oncology

JF - Community Oncology

SN - 1548-5315

IS - 10

ER -